Mdxhealth is a front runner in epigenetic research with a proven track record of identifying, developing, validating and delivering molecular diagnostic assays. They provide functional genomic data that can be used for personalised cancer risk assessment, with specific focus on prostate cancer.
About the client Cergentis is a leading genomics company in the field of oncology and complete gene sequencing. Cergentis improves the quality of genetic research and human healthcare by empowering precision medicine and advanced genetic engineering. Based on their proprietary and widely published ...
